The brain's melanocortin peptide system — which controls appetite through POMC, AgRP, and neuropeptide Y — also regulates mood, potentially explaining why obesity and depression so often go hand in hand.
2 depression subtypesDSM-5 defines melancholic (weight loss) and atypical (weight gain) depression — both may involve melanocortin signaling
What the researchers found
The central melanocortin system — a brain circuitry driven by POMC, AgRP, and neuropeptide Y peptides acting on melanocortin receptors — plays a dual role in regulating both feeding behavior and mood. This shared circuitry may explain why obesity and depression so often co-occur.
The review highlights that DSM-5 recognizes two depression subtypes with opposite metabolic profiles: melancholic depression (decreased appetite, weight loss) and atypical depression (hyperphagia, weight gain, fatigue). Melanocortin signaling appears to be involved in both patterns, suggesting it acts as a biological bridge between metabolic state and emotional regulation.
Why it matters
Depression and obesity affect hundreds of millions of people worldwide and frequently overlap in the same patients. Understanding that shared peptide signaling circuits drive both conditions could lead to treatments that address metabolism and mood simultaneously, rather than treating each in isolation.
The numbers in context
Review article — synthesizes evidence across human and animal model studies
How the study worked
This is a narrative review examining the published literature on the melanocortin system's role in feeding and mood regulation, drawing from both human clinical data and animal model research. The authors synthesized evidence on POMC, AgRP, neuropeptide Y, and melanocortin receptors (MC3R, MC4R) across behavioral, metabolic, and psychiatric domains.
Who was studied
Review of human clinical and animal model studies on melanocortin signaling in metabolism and mood
What this study cannot tell us
As a narrative review, this paper synthesizes existing findings rather than presenting new experimental data. The melanocortin circuits linking mood and feeding are not yet fully mapped, and much of the evidence comes from animal models that may not directly translate to humans. The review acknowledges that the system's complexity means current understanding is incomplete.
How to read the evidence
As a narrative review in Biological Psychiatry (a top-tier psychiatric journal), this paper provides a well-sourced synthesis of existing evidence but does not contribute new experimental data. The melanocortin-mood connection is supported by animal studies but needs more human clinical validation.
When this study was published
Published in 2022, this review reflects current understanding of melanocortin neuroscience and is highly relevant to ongoing research on peptide-based treatments for metabolic and mood disorders.
The bigger picture
The melanocortin system is already a drug target — MC4R mutations cause severe obesity, and melanocortin-based drugs like setmelanotide treat rare genetic obesity. This review adds a psychiatric dimension, suggesting that melanocortin-targeting therapies could have mood effects (positive or negative) and that future drugs might be designed to address the metabolism-mood axis simultaneously. It also contextualizes why GLP-1 drugs, which interact with overlapping brain circuits, appear to affect mood and addictive behaviors.
Questions still open
- Could melanocortin receptor-targeting drugs be developed that treat both obesity and depression simultaneously?
- Do existing weight-loss drugs that affect brain appetite circuits (like GLP-1 agonists) also modulate melanocortin signaling and mood?
- Why do some depressed patients lose weight while others gain it — is the melanocortin system wired differently in each subtype?
Common questions
What is the melanocortin system and what does it do?
Why do obesity and depression so often occur together?
Read the original research
Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.
Biological psychiatry, 91(10), 879-887
Citation
Copperi, Francesca; Kim, Jung Dae; Diano, Sabrina. (2022). Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.. Biological psychiatry, 91(10), 879-887. https://doi.org/10.1016/j.biopsych.2021.05.026